SCHEMBL2169718

SCHEMBL2169718

COc1ccc(Oc2ccc(C(C)C(N)=O)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 2/20 0.58
ALOX5 P09917 2/20 0.50
EPHX1 P07099 1/20 0.50
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
PARP1 P09874 1/20 0.48
PARP2 Q9UGN5 1/20 0.48
PARP4 Q9UKK3 1/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
MAPT P10636 2/20 0.48
CYP3A4 P08684 1/20 0.48
PPARG P37231 1/20 0.48
LTA4H P09960 2/20 0.47
PTGS2 P35354 4/20 0.46
PTGS1 P23219 2/20 0.46
AKR1C3 P42330 2/20 0.46
AKR1C2 P52895 2/20 0.46
TSHR P16473 2/20 0.46
CDC42 P60953 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2370549 0.94 EPHX1 (0.55) PARP10ALOX5EPHX1CA1CA2
SCHEMBL2055565 0.94 EPHX1 (0.55) PARP10ALOX5EPHX1CA1CA2
SCHEMBL2173030 0.86 PARP10 (0.55) PARP10ALOX5EPHX1MEN1KMT2A
SCHEMBL2172240 0.86 EPHX1 (0.50) PARP10ALOX5EPHX1PARP4KMT2A
SCHEMBL456155 0.85 ACACB (0.60) PARP10ALOX5EPHX1CA1CA2
SCHEMBL2171656 0.84 EPHX1 (0.49) PARP10EPHX1PARP4KMT2APTGS2
SCHEMBL2170990 0.84 EPHX1 (0.49) EPHX1
SCHEMBL263373 0.79 PTGS2 (0.73) ALOX5CA1CA2MAPTPTGS2
SCHEMBL1478228 0.79 PTGS2 (0.73) ALOX5CA1CA2MAPTPTGS2
SCHEMBL30760568 0.79 PTGS2 (0.73) ALOX5CA1CA2MAPTPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346821-A1 SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS Exelixis, Inc. (US) 2011-07-27 EP disclosed
WO-2010045580-A1 SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS EXELIXIS, INC. (US) 2010-04-22 WO disclosed